-
Posted by
Two Blokes May 21 -
Filed in
Stock
-
0 views
HQH offers a compelling mix of high yield and growth exposure to healthcare, trading at a discount to NAV with recent outperformance versus benchmarks. The fund benefits from strong healthcare industry tailwinds—aging populations and innovation—while active management and share buybacks support narrowing the NAV discount. A robust 13.6% market yield and a fair value estimate 36% above current price highlight significant upside, though distribution sustainability must be monitored.
